Editorial: Probiotics prevent allergic diseases in high-risk children

Expert Review of Clinical Immunology

Volumn 5, Issue 3, 2009, Pages 221-224

  Kuitunen, Mikael ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; ALLERGY; ATOPIC DERMATITIS; BIFIDOBACTERIACEAE; CHILD; EDITORIAL; FECES MICROFLORA; HIGH RISK PATIENT; HUMAN; IMMUNOSTIMULATION; LACTOBACILLUS; PREVALENCE;

EID: 77649171841     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.3     Document Type: Editorial

References (26)

1. Riedler J, Braun-Fahrlander C, Eder W et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358(9288), 1129-1133 (2001).
2. Waser M, Michels KB, Bieli C et al. Inverse association of farm milk consumption with asthma and allergy in rural and suburban populations across Europe. Clin. Exp. Allergy 37(5), 661-670 (2007).
3. Björksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29(3), 342-346 (1999).
4. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 353(9163), 1485-1488 (1999). (Pubitemid 29204367)
5. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99(2), 179-185 (1997).
6. Kalliomäki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebocontrolled trial. Lancet 357(9262), 1076-1079 (2001).
7. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361(9372), 1869-1871 (2003).
8. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J. Allergy Clin. Immunol. 119(4), 1019-1021 (2007).
9. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121(4), e850-e856 (2008).
10. Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, doubleblind, placebo-controlled trial. J. Allergy Clin. Immunol. 119(1), 192-198 (2007).
11. Kuitunen M, Kukkonen K, Juntunen-Backman K et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol. 123(2), 335-341 (2009).
12. Renz-Polster H, David MR, Buist AS et al. Cesarean section delivery and the risk of allergic disorders in childhood. Clin. Exp. Allergy 35(11), 1466-1472 (2005).
13. Hamilton BE, Minino AM, Martin JA et al. Annual summary of vital statistics: 2005. Pediatrics 119(2), 345-360 (2007).
14. Villar J, Carroli G, Zavaleta N et al. Maternal and neonatal individual risks and benefits associated with cesarean delivery: multicentre prospective study. BMJ 335(7628), 1025 (2007).
15. Adlerberth I, Strachan DP, Matricardi PM et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J. Allergy Clin. Immunol. 120(2), 343-350 (2007).
16. Wickens K, Black PN, Stanley TV et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a doubleblind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 122(4), 788-794 (2008).
17. Lassig A, Karjalainen H, Saxelin M et al. Oral and intestinal survival of probiotics given in different food matrixes. Presented at: SSA GutImpact: 3rd Platform Meeting on Foods for Intestinal Health. Haikko, Finland, 29-31 August 2007.
18. Viljanen M, Pohjavuori E, Haahtela T et al. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 115(6), 1254-1259 (2005).
19. Pohjavuori E, Viljanen M, Korpela R et al. Lactobacillus GG effect in increasing IFN-g production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 114(1), 131-136 (2004).
20. Adlerberth I, Jalil F, Carlsson B et al. High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol. Infect. 121(3), 587-598 (1998).
21. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J. Allergy Clin. Immunol. 119(1), 184-191 (2007).
22. Sudo N, Sawamura S, Tanaka K et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159(4), 1739-1745 (1997).
23. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63(10), 3904-3913 (1995).
24. Adlerberth I, Lindberg E, Aberg N et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Pediatr. Res. 59(1), 96-101 (2006).
25. Verhasselt V, Milcent V, Cazareth J et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat. Med. 14(2), 170-175 (2008).
26. Björksten B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin. Immunopathol. 25(3-4), 257-270 (2004).